ClinicalTrials.Veeva

Menu
H

Hemophilia Center of Western PA | Pittsburgh, PA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Emicizumab
rFIXFc
Tranexamic Acid
VGA039

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

The purpose of the study is to evaluate the safety, tolerability and time-course profile of FVIII activity after dosing with SB-525 (PF-07055480)

Active, not recruiting
Hemophilia A
Biological: SB-525 (PF-07055480)
Locations recently updated

This is a multi-center, Phase 1a study to assess the safety, tolerability, PK, and PD of VGA039 following single IV or SC dose administration in heal...

Enrolling
Von Willebrand Diseases
Other: Placebo
Drug: VGA039

Trial sponsors

M
Baxalta logo
B
B
Pfizer logo
V
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems